Patent for new antimicrobial formula
A variety of factors can induce chronic pharyngitis, including, repeated episodes of acute pharyngitis, upper respiratory tract diseases, changes in climate and geographical environment, temperature, humidity, poor air quality, tobacco and alcohol stimulation.
Moreover, it can caused by spicy food, dust, harmful gases, radioactive radiation, and/or systemic factors. Traditionally, clinicians have mainly used antibiotics and/ or anti-inflammatory medications to control microbial infections and inflammation associated with chronic pharyngitis. These drugs typically have an unpleasant taste, are prematurely discontinued by patients, and have other complications.
Thus, a therapy for such inflammation of pharyngeal mucosal tissue solving the aforementioned problems is desired.
Although it is in its preliminary clinical trial, this new medicament formula could potentially be purposed as a treatment for such inflammation of pharyngeal mucosal tissue medication, according to encouraging data from the preclinical trial.
The drug anti-microbial formula composition consists of tropical plants and the peel of the pomegranate extracts. The therapeutic composition can also be used to sterilise wounds, skin ulcers, necrosis and burns.
As well as it can be used as oral disinfectant agent in the form of a chewing gum, and in other disinfectant forms for domestic daily uses.